WHO
© Credits

Zika virus disease

    Overview

    Zika virus is primarily transmitted by the bite of an infected mosquito from the Aedes genus, mainly Aedes aegypti, in tropical and subtropical regions. Aedes mosquitoes usually bite during the day, peaking during early morning and late afternoon/evening. This is the same mosquito that transmits dengue, chikungunya and yellow fever.

    Zika virus is also transmitted from mother to fetus during pregnancy, through sexual contact, transfusion of blood and blood products, and organ transplantation.

    WHO declared a public health emergency of international concern regarding microcephaly, other neurological disorders and Zika virus from February to November 2016. Cases of Zika virus disease declined from 2017 onwards globally; however, Zika virus transmission persists at low levels in several countries in the Americas and in other endemic regions. To date, a total of 89 countries and territories have reported evidence of mosquito transmitted Zika virus infection, however surveillance remains limited globally.

    No vaccine is yet available for the prevention or treatment of Zika virus infection. Development of a Zika vaccine remains an active area of research

    The history of Zika virus

    Symptoms and treatment
    The incubation period (the time from exposure to symptoms) of Zika virus disease is estimated to be 314 days. The majority of people infected with Zika virus do not develop symptoms.

    Symptoms are generally mild including fever, rash, conjunctivitis, muscle and joint pain, malaise, and headache, and usually last for 27 days.

    Complications of Zika virus disease

    Zika virus infection during pregnancy is a cause of microcephaly and other congenital abnormalities in the developing fetus and newborn. Zika infection in pregnancy also results in pregnancy complications such as fetal loss, stillbirth, and preterm birth.  

    Zika virus infection is also a trigger of Guillain-Barré syndrome, neuropathy and myelitis, particularly in adults and older children.

    Research is ongoing to investigate the effects of Zika virus infection on pregnancy outcomes, strategies for prevention and control, and effects of infection on other neurological disorders in children and adults.

    Prevention and control
    Protection against mosquito bites during the day and early evening is a key measure to prevent Zika virus infection. Special attention should be given to prevention of mosquito bites among pregnant women, women of reproductive age, and young children.

    Personal protection measures include wearing clothing (preferably light-coloured) that covers as much of the body as possible; using physical barriers such as window screens and closed doors and windows; and applying insect repellent to skin or clothing that contains DEET, IR3535 or icaridin according to the product label instructions.

    Young children and pregnant women should sleep under mosquito nets if sleeping during the day or early evening.  Travellers and those living in affected areas should take the same basic precautions described above to protect themselves from mosquito bites.

    Prevention of sexual transmission of Zika virus

    Aedes mosquitoes breed in small collections of water around homes, schools, and work sites. It is important to eliminate these mosquito breeding sites, including: covering water storage containers, removing standing water in flower pots, and cleaning up trash and used tires. Community initiatives are essential to support local government and public health programs to reduce mosquito breeding sites.  Health authorities may also advise use of larvicides and insecticides to reduce mosquito populations and disease spread.

    Vector control operations framework for Zika virus

     

    Policy considerations for strengthening preparedness and response to arbovirus epidemics and pandemics

    The increasing incidence of arboviral outbreaks, such as dengue, chikungunya, and Zika, highlights the need for urgent and stronger preparedness and response...

    WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever

    World Health Organization (WHO) has just released the Integrated Guidelines on the Clinical Management of Arboviral Diseases — a crucial step...

    Report on the global arbovirus surveillance and response capacity survey 2021-2022

    In 2021-2022 the World Health Organization (WHO) conducted a survey to assess current surveillance and response guidelines and practices across WHO Member...

    Risk communication and community engagement readiness and response toolkit: zika virus

    This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE)...

    Documents

    All →

    For the development of the guidelines for the clinical management and diagnosis of dengue, chikungunya, Zika and yellow fever, a Guideline Development...

    This document provides a list of Flavirus vaccines and therapeutics licensed or under development for pathogens being considered as PRIORITY PATHOGENS.

    World Health Organization compiles periodic summaries of the global epidemiology of Zika virus transmission, and the most recent compilation of data has...

    The Global Preparedness and Monitoring Board (GPMB) works with countries to improve pandemic and other disease outbreak preparedness. The GPMB's ​2023...

    Guidance

    Related links

    zika-youtube-videos-paho

    Zika virus disease videos in different languages (YouTube)

    Pan American Health Organization